Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2007 1
2010 2
2011 3
2013 2
2014 3
2016 2
2017 2
2018 2
2019 1
2020 4
2021 3
2022 2
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

25 results

Results by year

Filters applied: . Clear all
Page 1
The future of precise cancer chronotherapeutics.
Innominato PF, Karaboué A, Bouchahda M, Bjarnason GA, Lévi FA. Innominato PF, et al. Among authors: karaboue a. Lancet Oncol. 2022 Jun;23(6):e242. doi: 10.1016/S1470-2045(22)00188-7. Lancet Oncol. 2022. PMID: 35654059 No abstract available.
Reply to P. Gazzaniga et al.
Bouchahda M, Saffroy R, Karaboué A, Hamelin J, Innominato P, Saliba F, Bosselut N, Lemoine A, Lévi F. Bouchahda M, et al. Among authors: karaboue a. JCO Precis Oncol. 2021 Nov;5:391-392. doi: 10.1200/PO.20.00465. JCO Precis Oncol. 2021. PMID: 34994602 No abstract available.
Rest-activity rhythm as a clinical biomarker in cancer.
Innominato PF, Wreglesworth NI, Karaboué A, Spiegel D, Lévi FA. Innominato PF, et al. Among authors: karaboue a. Lancet Healthy Longev. 2023 Jul;4(7):e304. doi: 10.1016/S2666-7568(23)00108-3. Lancet Healthy Longev. 2023. PMID: 37421957 Free article. No abstract available.
Circadian rest-activity rhythm as an objective biomarker of patient-reported outcomes in patients with advanced cancer.
Innominato PF, Komarzynski S, Palesh OG, Dallmann R, Bjarnason GA, Giacchetti S, Ulusakarya A, Bouchahda M, Haydar M, Ballesta A, Karaboué A, Wreglesworth NI, Spiegel D, Lévi FA. Innominato PF, et al. Among authors: karaboue a. Cancer Med. 2018 Sep;7(9):4396-4405. doi: 10.1002/cam4.1711. Epub 2018 Aug 7. Cancer Med. 2018. PMID: 30088335 Free PMC article.
Sex-dependent least toxic timing of irinotecan combined with chronomodulated chemotherapy for metastatic colorectal cancer: Randomized multicenter EORTC 05011 trial.
Innominato PF, Ballesta A, Huang Q, Focan C, Chollet P, Karaboué A, Giacchetti S, Bouchahda M, Adam R, Garufi C, Lévi FA. Innominato PF, et al. Among authors: karaboue a. Cancer Med. 2020 Jun;9(12):4148-4159. doi: 10.1002/cam4.3056. Epub 2020 Apr 22. Cancer Med. 2020. PMID: 32319740 Free PMC article. Clinical Trial.
25 results